Template:Serotonin syndrome vs neuroleptic malignant syndrome: Difference between revisions
(Created page with "===Serotonin syndrome vs neuroleptic malignant syndrome=== *Differentiation between the serotonin syndrome and NMS can be challenging. History of a new seroton...") |
|||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
===[[Serotonin syndrome]] vs [[ | ===[[Serotonin syndrome]] vs [[Neuroleptic malignant syndrome]]=== | ||
* | *History of a new serotonergic drug or a dose increase of a serotonergic drug are helpful | ||
*Elevations in | *Serotonin syndrome is usually much more acute in onset than NMS which may develop over days or weeks | ||
*Presence of ‘lead pipe’ rigidity is typical of NMS, while serotonin syndrome typically manifests with tremor and hyperreflexia | |||
*Elevations in CK, LFTs, and WBC, coupled with a low iron level, distinguishes NMS from serotonin syndrome among patients taking both neuroleptic and serotonin agonist medications simultaneously |
Latest revision as of 04:33, 13 February 2017
Serotonin syndrome vs Neuroleptic malignant syndrome
- History of a new serotonergic drug or a dose increase of a serotonergic drug are helpful
- Serotonin syndrome is usually much more acute in onset than NMS which may develop over days or weeks
- Presence of ‘lead pipe’ rigidity is typical of NMS, while serotonin syndrome typically manifests with tremor and hyperreflexia
- Elevations in CK, LFTs, and WBC, coupled with a low iron level, distinguishes NMS from serotonin syndrome among patients taking both neuroleptic and serotonin agonist medications simultaneously